Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

Friday’s trading has closed, but PFE is being traded in the after-hours session. After-Hours quote »
Delayed Data
As of 4:01pm ET
 +0.15 / +0.45%
Today’s Change
Today|||52-Week Range
Eli Lilly's Breast Cancer Drug Gets Breakthrough Status
5:17pm / Zacks.com
Technically talented lawyers are increasingly valued
Oct 01 / FT.com
Dow 30 Stock Roundup: Microsoft Launces Surface Book, Merck's Keytruda Approved for L...
3:38pm / Zacks.com
Pfizer Raises 2015 Outlook on Hospira Acquisition, Shares Up
Oct 01 / Zacks.com
Stocks Rally as March Rate Hike Most Likely
Oct 08 / TheStreet.com
Pfizer Boosts Its Guidance, Suggesting Better Times May Be Coming
Sep 30 / MotleyFool.com
Merck KGaA/Pfizer's Avelumab Gets Fast Track Status
Oct 08 / Zacks.com
Buy 3 Compelling Biotech Stocks at Bargain Prices
Sep 29 / Zacks.com
5 Sector Favorites for Q3 Earnings & Their Hot ETFs
Oct 08 / Zacks.com
Which Big Pharma Will Grab the Lionbs Share of the Cancer Immunotherapy Market?
Sep 29 / MotleyFool.com
Stocks Rise as Investors Interpret Fed Minutes as Dovish
Oct 08 / TheStreet.com
Roche's Primary Progressive MS Drug Positive in Phase III
Sep 28 / Zacks.com
Valeant under pressure over price rises
Oct 08 / FT.com
Biotech stocks fall further as Hillary Clinton unveils drug policy
Sep 22 / FT.com
3 Drugs Stocks Moving The Industry Upward
Oct 07 / TheStreet.com
FT Explainer: How US biotech valuations got stretched
Sep 22 / FT.com
Recession-Proofing Your Portfolio
Oct 07 / TheStreet.com
Businesses tell Marco Rubio: Change your Cuba stance
Sep 14 / CNNMoney.com
Biotech Is Healthy in a Slowing Economy
Oct 05 / TheStreet.com
Judge rounds on Pfizer in UK blockbuster patent case
Sep 10 / FT.com
Dow 30 Stock Roundup: NIKE Beats Estimates, Pfizer Ups 2015 Outlook, Microsoft Change...
Oct 02 / Zacks.com
Shazam CFO jumps to drug research app TrialReach
Sep 09 / FT.com
Merck KGaA's Pipeline on Track, Updates Key R&D Projects
Oct 02 / Zacks.com